![Chad Gassert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chad Gassert
Corporate Officer/Principal bei ANI PHARMACEUTICALS, INC.
Vermögen: 15 Mio $ am 30.06.2024
Aktive Positionen von Chad Gassert
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ANI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 19.11.2021 | - |
Karriereverlauf von Chad Gassert
Ehemalige bekannte Positionen von Chad Gassert
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Novitium Pharma LLC
![]() Novitium Pharma LLC Pharmaceuticals: OtherHealth Technology Part of ANI Pharmaceuticals, Inc., Novitium Pharma LLC is a pharmaceutical company that specializes in the development, manufacturing, and distribution of niche generic products. The private company was founded in 2016 by Muthusamy Shanmugam, Chad Gassert, and Vijay Thorappadi and is based in East Windsor, NJ, with operations also in Chennai. Novitium has a growing commercial product portfolio spanning a diverse range of dosage forms and therapeutic categories. Novitium continues to invest in producing affordable, high-quality medication to fulfill the needs of pharmacists, patients, and communities. Novitium Pharma was acquired by ANI Pharmaceuticals, Inc. on November 22, 2021 for $243.40 million. | Vorstandsvorsitzender | 01.06.2016 | 01.11.2021 |
Gründer | 01.01.2016 | 01.11.2021 | |
PAR PHARMACEUTICAL COMPANIES, INC. | Corporate Officer/Principal | - | 01.01.2016 |
Par Pharmaceutical, Inc.
![]() Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Corporate Officer/Principal | 01.01.2005 | 01.01.2016 |
Ausbildung von Chad Gassert
University of Delaware | Undergraduate Degree |
New Jersey Institute of Technology | Graduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ANI PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Endo Generics Holdings, Inc.
![]() Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |
Par Pharmaceutical, Inc.
![]() Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Health Technology |
Novitium Pharma LLC
![]() Novitium Pharma LLC Pharmaceuticals: OtherHealth Technology Part of ANI Pharmaceuticals, Inc., Novitium Pharma LLC is a pharmaceutical company that specializes in the development, manufacturing, and distribution of niche generic products. The private company was founded in 2016 by Muthusamy Shanmugam, Chad Gassert, and Vijay Thorappadi and is based in East Windsor, NJ, with operations also in Chennai. Novitium has a growing commercial product portfolio spanning a diverse range of dosage forms and therapeutic categories. Novitium continues to invest in producing affordable, high-quality medication to fulfill the needs of pharmacists, patients, and communities. Novitium Pharma was acquired by ANI Pharmaceuticals, Inc. on November 22, 2021 for $243.40 million. | Health Technology |
- Börse
- Insiders
- Chad Gassert
- Erfahrung